Miromatrix Medical Inc. and its directors allegedly misled investors about a pending $91 million acquisition by United Therapeutics Corp., according to a shareholder lawsuit.
The bioengineering company allegedly issued a misleading solicitation statement recommending that shareholders tender their shares in the proposed buyout, according to a complaint filed Wednesday is US District Court for the District of Delaware.
Key details allegedly omitted from the Nov. 13 solicitation statement include financial forecasts and analyses that supported financial advisor Piper Sandler & Co’s fairness opinion, as well as potential conflicts of interest faced by Craig-Hallum Capital Group LLC, another ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.